What the eye area actually needs

Eye creams occupy a category built more on packaging than on pharmacology. The skin around the orbit is thinner, poorer in sebaceous glands and quicker to react, all of which is true and none of which requires a separate jar at four times the price per gram. What that skin genuinely needs turns out to be short, unglamorous and slow.

The eyelid and the skin beneath it are the thinnest on the body, roughly a third of the thickness found on the cheek, with fewer oil glands and a barrier that is easier to disturb. That is the honest anatomical case, and it justifies exactly two things: gentler handling, and a lower concentration of anything active. It does not justify a separate formulation, which is why so many eye creams are the brand's face moisturiser at a lighter viscosity, decanted into fifteen millilitres and priced as though the difference were chemical rather than commercial. A fragrance free moisturiser containing glycerin, a ceramide blend or squalane will do the hydrating work perfectly well, applied with a fraction of the pressure used elsewhere and kept off the lash line, where migration into the eye causes most of the stinging blamed on the ingredients. Where a dedicated product does earn its place is in tolerability. A retinoid at a quarter of the strength worn on the face, in a buffered base, is a sensible way to introduce an active to skin that will complain first and loudest. Most complaints about the eye area, though, are not really about the skin's surface. They concern darkness and shadow, and those have separate causes that respond to entirely different things, or in some cases to nothing topical at all. Sorting out which one is present is more useful than any purchase, and it can usually be done at a mirror in reasonable light.

Dark circles are a description of an appearance, not a diagnosis. Three quite different mechanisms produce them, often in combination, and the distinction determines whether a cream has any prospect of helping or whether the shadow is structural and will not move.

The first is pigment: a genuine deposit of melanin, common in deeper skin tones and frequently inherited, sometimes worsened by rubbing or by eczema around the orbit. This is the type most likely to respond to topical work, specifically to sun protection, to a low strength retinoid and to tyrosinase inhibitors such as azelaic acid, applied consistently over months. The second is vascular: blood in the thin plexus beneath translucent skin, read by the eye as blue or purple, worse with fatigue, dehydration, allergy and nasal congestion. Caffeine constricts those vessels briefly, which is why caffeine serums produce a real but transient improvement, best measured in hours. Antihistamines and treating an allergy properly tend to do more. The third is structural, and it is the reason so much money is wasted. A hollow at the tear trough, a loss of volume beneath the orbital rim, or fat that has begun to protrude above it, casts a shadow. Shadows are geometry. No cream repositions bone, fat or ligament, and any product claiming to has changed the subject from the evidence to the photography. Whichever mechanism applies, the timeline is the part most often misrepresented. Epidermal turnover, the accumulation of new collagen and the settling of pigment run on a schedule of weeks, not days. Twelve weeks is the honest minimum for judging any active in this area, which is roughly how long a well conducted trial runs before it measures anything, and it should be judged against a photograph taken at the start in the same light rather than against memory. Anything reported at two weeks is hydration, which is worth having and is not the same claim.